Passage Bio (PASG) Competitors $7.70 -0.02 (-0.19%) As of 10:41 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PASG vs. CNTB, QNCX, HYPD, ATRA, IFRX, VXRT, XBIT, IRD, ENTX, and CRVOShould you be buying Passage Bio stock or one of its competitors? The main competitors of Passage Bio include Connect Biopharma (CNTB), Quince Therapeutics (QNCX), Hyperion DeFi (HYPD), Atara Biotherapeutics (ATRA), InflaRx (IFRX), Vaxart (VXRT), XBiotech (XBIT), Opus Genetics (IRD), Entera Bio (ENTX), and CervoMed (CRVO). These companies are all part of the "pharmaceutical products" industry. Passage Bio vs. Its Competitors Connect Biopharma Quince Therapeutics Hyperion DeFi Atara Biotherapeutics InflaRx Vaxart XBiotech Opus Genetics Entera Bio CervoMed Passage Bio (NASDAQ:PASG) and Connect Biopharma (NASDAQ:CNTB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends. Is PASG or CNTB more profitable? Connect Biopharma's return on equity of 0.00% beat Passage Bio's return on equity.Company Net Margins Return on Equity Return on Assets Passage BioN/A -103.87% -59.95% Connect Biopharma N/A N/A N/A Which has stronger earnings and valuation, PASG or CNTB? Connect Biopharma has higher revenue and earnings than Passage Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPassage BioN/AN/A-$64.77M-$18.16-0.42Connect Biopharma$1.97M48.07-$15.63MN/AN/A Which has more risk & volatility, PASG or CNTB? Passage Bio has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Comparatively, Connect Biopharma has a beta of -0.09, indicating that its stock price is 109% less volatile than the S&P 500. Does the media prefer PASG or CNTB? In the previous week, Passage Bio and Passage Bio both had 1 articles in the media. Passage Bio's average media sentiment score of 0.00 equaled Connect Biopharma'saverage media sentiment score. Company Overall Sentiment Passage Bio Neutral Connect Biopharma Neutral Do institutionals and insiders hold more shares of PASG or CNTB? 53.5% of Passage Bio shares are owned by institutional investors. Comparatively, 58.7% of Connect Biopharma shares are owned by institutional investors. 5.0% of Passage Bio shares are owned by insiders. Comparatively, 22.6% of Connect Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts rate PASG or CNTB? Passage Bio currently has a consensus price target of $75.67, suggesting a potential upside of 882.05%. Connect Biopharma has a consensus price target of $7.00, suggesting a potential upside of 312.98%. Given Passage Bio's higher probable upside, analysts clearly believe Passage Bio is more favorable than Connect Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Passage Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Connect Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryConnect Biopharma beats Passage Bio on 8 of the 11 factors compared between the two stocks. Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PASG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PASG vs. The Competition Export to ExcelMetricPassage BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.49M$3.11B$5.70B$10.23BDividend YieldN/A2.36%5.68%4.61%P/E Ratio-0.4220.6376.0426.13Price / SalesN/A387.65516.68165.77Price / CashN/A45.9137.5661.52Price / Book0.399.7612.676.32Net Income-$64.77M-$52.73M$3.29B$270.94M7 Day Performance2.05%0.63%0.09%-0.10%1 Month Performance3.15%6.30%4.14%6.37%1 Year Performance-39.81%18.52%65.69%28.45% Passage Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PASGPassage Bio3.3791 of 5 stars$7.71-0.2%$75.67+882.0%-39.2%$24.49MN/A-0.42130CNTBConnect Biopharma3.1098 of 5 stars$1.60+2.6%$7.00+337.5%+39.8%$86.93M$26.03M0.00110QNCXQuince Therapeutics3.7932 of 5 stars$1.60flat$8.14+408.9%+114.6%$85.94MN/A-1.4760News CoveragePositive NewsGap UpHYPDHyperion DeFi0.2871 of 5 stars$11.56-22.8%$2.00-82.7%-73.5%$85.31M$60K-0.2040News CoverageGap DownHigh Trading VolumeATRAAtara Biotherapeutics4.5832 of 5 stars$11.94-1.5%$21.00+75.9%+88.9%$85.12M$128.94M-27.77330Positive NewsIFRXInflaRx2.5036 of 5 stars$1.23-2.4%$6.20+404.1%-11.7%$84.59M$180K-1.5460Gap UpVXRTVaxart2.0323 of 5 stars$0.37-6.0%$2.00+445.6%-56.2%$83.93M$47.40M-1.36120Gap DownXBITXBiotech1.7563 of 5 stars$2.72-1.1%N/A-58.8%$83.84M$4.01M-2.96100Positive NewsIRDOpus Genetics1.8414 of 5 stars$1.37-0.7%$7.33+435.3%N/A$82.67M$10.99M-0.7114ENTXEntera Bio1.3166 of 5 stars$1.83+1.7%$10.00+446.4%-8.2%$82.19M$166K-7.0420Positive NewsCRVOCervoMed3.7187 of 5 stars$8.54-3.5%$19.29+125.8%-46.6%$81.89M$9.74M-3.274Positive News Related Companies and Tools Related Companies CNTB Alternatives QNCX Alternatives HYPD Alternatives ATRA Alternatives IFRX Alternatives VXRT Alternatives XBIT Alternatives IRD Alternatives ENTX Alternatives CRVO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PASG) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PASG Stock Alerts